Journal of Ophthalmology

Age Macular Degeneration: Etiology, Prevention, Individualized Therapies, Cell Therapy, and Tissue Engineering


Publishing date
13 Dec 2013
Status
Published
Submission deadline
26 Jul 2013

Guest Editors

1Department of Ophthalmology, University Clinic of Navarra, Pamplona, Spain

2Department of Ophthalmology, University Hospital of Geneva, Geneva, Switzerland

3Department for Functional Materials in Medicine and Dentistry, University Hospital of Würzburg, Würzburg , Germany


Age Macular Degeneration: Etiology, Prevention, Individualized Therapies, Cell Therapy, and Tissue Engineering

Description

Age macular degeneration (AMD) is one of the leading causes of vision loss and is the most common cause of legal blindness in industrialized countries. The dramatic loss of autonomy and life quality associated with AMD leads to increased costs for health care and long-term care. As AMD is caused by degeneration of the retina mainly due to processes related to ageing, its prevalence and the associated costs for health care are expected to increase as the population ages. The aetiology of AMD is unknown; however, the development of AMD is dependent on genetic as well as environmental factors as diet and smoking. Above all, age is the most prevalent factor, and rates increase significantly in individuals older than 50 years. A portion of patients with neovascular AMD can be treated with inhibitors of vascular endothelial growth factor (VEGF), but no treatments are available for the nonvascular one. So preventive strategies, improving the use of current pharmacologic treatments, and the development of new therapies are the main challenges in the future management of this disease.

The main focus of the special issue is the recent developments in preventive and therapeutic strategies in age macular treatment. Original research articles, reviews, and clinical studies’ are welcomed. Potential topics include, but are not limited to:

  • Socioeconomics burden of AMD
  • Genetic risk factors in AMD
  • Environmental risk factors in AMD
  • Dietary supplements in AMD
  • Early diagnosis in AMD
  • Individualized treatment protocols in wet AMD
  • Pharmacogenetic response in wet AMD
  • Future therapies in wet AMD
  • Future therapies in dry AMD
  • Mutations affecting the photopigment cycle: perspectives for individualized therapy
  • Slow delivery of drugs in AMD treatment
  • Perspectives for nanotechnology applications in AMD treatment: where do we stand?
  • Protecting and regenerating the retinal pigment epithelium in AMD: advances in pharmacology
  • Cell-based therapy in AMD
  • Tissue-engineered therapy in AMD
  • Vision rehabilitation strategies in AMD
  • Retinal prosthesis and implants: the newest developments

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/jop/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/jop/agem/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 287893
  • - Editorial

Age Macular Degeneration: Etiology, Prevention, Individualized Therapies, Cell Therapy, and Tissue Engineering

Alfredo García-Layana | Gabriele Thumann | Jürgen Groll
  • Special Issue
  • - Volume 2014
  • - Article ID 346360
  • - Clinical Study

Age-Related Macular Degeneration: Clinical Findings following Treatment with Antiangiogenic Drugs

Ricardo Casaroli-Marano | Roberto Gallego-Pinazo | ... | Jordi Farrés Martí
  • Special Issue
  • - Volume 2014
  • - Article ID 901686
  • - Review Article

Do Nutritional Supplements Have a Role in Age Macular Degeneration Prevention?

Maria D. Pinazo-Durán | Francisco Gómez-Ulla | ... | Alfredo García-Layana
  • Special Issue
  • - Volume 2014
  • - Article ID 510285
  • - Review Article

Current Treatment Limitations in Age-Related Macular Degeneration and Future Approaches Based on Cell Therapy and Tissue Engineering

P. Fernández-Robredo | A. Sancho | ... | A. García-Layana
  • Special Issue
  • - Volume 2013
  • - Article ID 135798
  • - Clinical Study

Long-Term Outcomes of Rheohaemapheresis in the Treatment of Dry Form of Age-Related Macular Degeneration

Jan Studnička | Eva Rencová | ... | Hana Langrová
  • Special Issue
  • - Volume 2013
  • - Article ID 895147
  • - Review Article

Smoking and Age-Related Macular Degeneration: Review and Update

Sara Velilla | José Javier García-Medina | ... | Roberto Gallego-Pinazo
  • Special Issue
  • - Volume 2013
  • - Article ID 216359
  • - Research Article

Optimization of Storage Temperature for Cultured ARPE-19 Cells

Lara Pasovic | Tor Paaske Utheim | ... | Jon Roger Eidet
  • Special Issue
  • - Volume 2013
  • - Article ID 862806
  • - Research Article

Efficacy of Ethanol Extract of Fructus lycii and Its Constituents Lutein/Zeaxanthin in Protecting Retinal Pigment Epithelium Cells against Oxidative Stress: In Vivo and In Vitro Models of Age-Related Macular Degeneration

Xinrong Xu | Li Hang | ... | Wei Li
  • Special Issue
  • - Volume 2013
  • - Article ID 676049
  • - Research Article

Predictors of Visual Response to Intravitreal Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration

Kai Fang | Jun Tian | ... | Xiaoxin Li
Journal of Ophthalmology
 Journal metrics
Acceptance rate37%
Submission to final decision93 days
Acceptance to publication35 days
CiteScore1.780
Impact Factor1.580
 Submit